At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
Acute Normovolemic Hemodilutionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study Involving the Changes in the Markers of Coagulation During Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
In Brief
An observational study evaluating Acute Normovolemic Hemodilution for Bleeding Reduction. Completed, enrolled 43 participants across 1 site.
Detailed Summary
This study will help enhance current understanding of the impact of Acute Normovolemic Hemodilution (ANH) administration on transfusion requirements post cardiac surgery, the effect of this procedure on coagulation, and platelet hemostasis, and the amount of chest tube drainage 24 hours post coronary artery bypass graft surgery (CABG) surgery.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBleeding Reduction
CountriesUnited States
CollaboratorsInstrumentation Laboratory
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartMar 2018
Primary CompletionSep 2019
Study CompletionOct 2019
TodayJul 2026
First PostedOct 31, 2017
Enrollment StartMar 19, 2018
Primary CompletionSep 17, 2019
Study CompletionOct 17, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.7 years ago
Interventions
Acute Normovolemic Hemodilutionprocedure
Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.